mPFS 9.2m (all patients)
mPFS 11.4m (for kinase domain mutants H1047R)
Clinical Benefit Rate 67%
#bcsm @breastcancernow.bsky.social
mPFS 9.2m (all patients)
mPFS 11.4m (for kinase domain mutants H1047R)
Clinical Benefit Rate 67%
#bcsm @breastcancernow.bsky.social
Sobre crimes ambientais, Bolsonaro está "anistiado" não só pela omissão do sistema Globo, que evita citar seu nome, mas também pelos hipócritas que transitam nos MPFs e no PGR.
Com caneta ou microfone nas mãos, Bolsonaro matou milhões, inclusive, fauna e flora.
@stf.jus.br
Sobre crimes ambientais, Bolsonaro está "anistiado" não só pela omissão do sistema Globo, que evita citar seu nome, mas também pelos hipócritas que transitam nos MPFs e no PGR.
Com caneta ou microfone nas mãos, Bolsonaro matou milhões, inclusive, fauna e flora.
@stf.jus.br
Fikirlerin Dili'nde, İlahiyatçı-Yazar Necdet İçel Hocamızla haftalık sohbetlere yaklaşık 1 yıl aradan sonra yeniden başlıyoruz.
Türkiye:20.45 Avrupa: 18.45 İngiltere: 17.45 ABD Doğu-Kanada:12.45
www.youtube.com/watch?v=MpfS...
Fikirlerin Dili'nde, İlahiyatçı-Yazar Necdet İçel Hocamızla haftalık sohbetlere yaklaşık 1 yıl aradan sonra yeniden başlıyoruz.
Türkiye:20.45 Avrupa: 18.45 İngiltere: 17.45 ABD Doğu-Kanada:12.45
www.youtube.com/watch?v=MpfS...
📣 #FDA has approved trastuzumab deruxtecan + pertuzumab for 1st-line tx of adults w/ HER2+ unresectable or #MetastaticBreastCancer based on DB-09 trial:
🏆44% ⬇️ in risk of progression/death vs THP (mPFS: 40.7 vs 26.9 mos).
⚠️ ILD ~12%
Google drugs@FDA for current label
📣 #FDA has approved trastuzumab deruxtecan + pertuzumab for 1st-line tx of adults w/ HER2+ unresectable or #MetastaticBreastCancer based on DB-09 trial:
🏆44% ⬇️ in risk of progression/death vs THP (mPFS: 40.7 vs 26.9 mos).
⚠️ ILD ~12%
Google drugs@FDA for current label
"Wage Setting in Multiproduct Firms"
by Chan, Irlacher (@michaelirlacher.bsky.social), Koch, and Macedoni
Link: ideas.repec.org/p/jku/econwp...
#EconSky
✅ Endpoint met
👉mPFS 11.2(C)vs17.5 months(I)
👉NO detrimental effect on OS
👉DCR 94.2%(C)vs91%(I)
👉Reduced toxicity
ascopubs.org/doi/pdf/10.1...
✅ Endpoint met
👉mPFS 11.2(C)vs17.5 months(I)
👉NO detrimental effect on OS
👉DCR 94.2%(C)vs91%(I)
👉Reduced toxicity
ascopubs.org/doi/pdf/10.1...
Det här är ju särskilt intressant. Mycket konstigt drag av MPF, som nog får somliga att ifrågasätta myndighetens politiska neutralitet
Det här är ju särskilt intressant. Mycket konstigt drag av MPF, som nog får somliga att ifrågasätta myndighetens politiska neutralitet
You must ask:
👉 What is the absolute benefit in PFS & how does it compare to imaging interval? (Note scans may get less frequent w/ time in trials so 👀 on that too dep on mPFS). If mPFS diff is < time btwn scans, hard to know if real.
@oncoalert.bsky.social
You must ask:
👉 What is the absolute benefit in PFS & how does it compare to imaging interval? (Note scans may get less frequent w/ time in trials so 👀 on that too dep on mPFS). If mPFS diff is < time btwn scans, hard to know if real.
@oncoalert.bsky.social
#bluelz #medien #games #Jugendliche #JIMStudie
mpfs.de
#bluelz #medien #games #Jugendliche #JIMStudie
mpfs.de
❇️ ORR 36 - 43%
❇️ mPFS 9.5 - 11.7m
❇️ DoR longer in 6mg/kg grp
❗️ 65% Dato dose reduction
❗️ 60% Dato dose interr
💭 Active combination
💭 Toxic+
💭 Not biomarker directed
#ELCC25
❇️ ORR 36 - 43%
❇️ mPFS 9.5 - 11.7m
❇️ DoR longer in 6mg/kg grp
❗️ 65% Dato dose reduction
❗️ 60% Dato dose interr
💭 Active combination
💭 Toxic+
💭 Not biomarker directed
#ELCC25
www.reddit.com/r/science/s/...
www.reddit.com/r/science/s/...
www.youtube.com/watch?v=mPfs...
www.youtube.com/watch?v=mPfs...